A Prescription Drug User Fee Act target date of December 10, 2025 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics ...

Experts provide an update regarding current understanding and management of aplastic anemia in a new review. 1 Eliska Furlong, MD, PhD, with the Perth Children’s Hospital, in Australia, and colleague ...

GRAND RAPIDS, Mich. — At just 18 years old, Lilly VandenBosch has already faced a lifetime of challenges. Diagnosed with aplastic anemia, a rare blood disorder, at the age of 7, her journey has been ...

Recurrent respiratory infections and a mediastinal mass prompted evaluation and diagnosis of Good syndrome — a ...

What Is Omisirge, and Why Does It Matter? Omisirge (omidubicel-onlv) is a type of cell therapy made from umbilical cord blood. It helps your body make new blood cells after a stem cell transplant.

Please provide your email address to receive an email when new articles are posted on . Outcomes after haploidentical transplant for severe aplastic anemia have improved significantly with use of post ...

HealthDay News — Recommendations for the diagnosis and management of severe acquired aplastic anemia are presented in a clinical practice guideline issued by the American Society of Hematology and ...

A comparison clinical study of two aplastic anemia treatments found that ATGAM, currently the only licensed aplastic anemia drug in the United States, improved blood cell counts and survival ...

Please provide your email address to receive an email when new articles are posted on . Prior trials established the role of haploidentical BMT for severe aplastic anemia. Two trials underway have the ...

Aplastic anemia is a rare disorder characterized by inadequate production of blood cells by the bone marrow. The bone marrow is a spongy tissue inside the bones, where all the blood cells (red blood ...